Operating Lease, Right-of-Use Asset of LakeShore Biopharma Co., Ltd. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LakeShore Biopharma Co., Ltd. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $118,042, a 88% decline year-over-year.
LakeShore Biopharma Co., Ltd. quarterly Operating Lease, Right-of-Use Asset in CNY history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was ¥847,331, a 88% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)
Operating Lease, Right-of-Use Asset, Quarterly (CNY)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LakeShore Biopharma Co., Ltd. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $118,042 -$907,380 -88% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 $1,025,422 -$594,618 -37% 31 Mar 2024 20-F 15 Aug 2024 2024 FY
Q1 2023 $1,620,040 31 Mar 2023 20-F 26 Jul 2023 2023 FY

LakeShore Biopharma Co., Ltd. Quarterly Operating Lease, Right-of-Use Asset (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 ¥847,331 -¥6,428,036 -88% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 ¥7,275,367 -¥3,857,061 -35% 31 Mar 2024 20-F 31 Jul 2025 2025 FY
Q1 2023 ¥11,132,428 -¥3,717,855 -25% 31 Mar 2023 20-F 15 Aug 2024 2024 FY
Q1 2022 ¥14,850,283 31 Mar 2022 20-F 26 Jul 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.